Stuart Chaussee & Associates’s CME Group CME Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-28
| Closed | -$7.57K | – | 33 |
|
|
2025
Q3 | $7.57K | Hold |
28
| – | – | ﹤0.01% | 157 |
|
|
2025
Q2 | $7.72K | Hold |
28
| – | – | ﹤0.01% | 156 |
|
|
2025
Q1 | $7.43K | Hold |
28
| – | – | ﹤0.01% | 162 |
|
|
2024
Q4 | $6.5K | Hold |
28
| – | – | ﹤0.01% | 160 |
|
|
2024
Q3 | $6.18K | Hold |
28
| – | – | ﹤0.01% | 144 |
|
|
2024
Q2 | $5.5K | Hold |
28
| – | – | ﹤0.01% | 146 |
|
|
2024
Q1 | $6.03K | Hold |
28
| – | – | ﹤0.01% | 142 |
|
|
2023
Q4 | $5.9K | Hold |
28
| – | – | ﹤0.01% | 132 |
|
|
2023
Q3 | $5.61K | Hold |
28
| – | – | ﹤0.01% | 113 |
|
|
2023
Q2 | $5.19K | Hold |
28
| – | – | ﹤0.01% | 118 |
|
|
2023
Q1 | $5.36K | Hold |
28
| – | – | ﹤0.01% | 114 |
|
|
2022
Q4 | $4.71K | Hold |
28
| – | – | ﹤0.01% | 133 |
|
|
2022
Q3 | $5K | Hold |
28
| – | – | 0.01% | 120 |
|
|
2022
Q2 | $6K | Hold |
28
| – | – | 0.01% | 122 |
|
|
2022
Q1 | $7K | Hold |
28
| – | – | ﹤0.01% | 134 |
|
|
2021
Q4 | $6K | Hold |
28
| – | – | ﹤0.01% | 145 |
|
|
2021
Q3 | $5K | Hold |
28
| – | – | 0.01% | 129 |
|
|
2021
Q2 | $6K | Hold |
28
| – | – | ﹤0.01% | 132 |
|
|
2021
Q1 | $6K | Hold |
28
| – | – | ﹤0.01% | 154 |
|
|
2020
Q4 | $5K | Hold |
28
| – | – | ﹤0.01% | 78 |
|
|
2020
Q3 | $5K | Hold |
28
| – | – | ﹤0.01% | 79 |
|
|
2020
Q2 | $5K | Hold |
28
| – | – | ﹤0.01% | 61 |
|
|
2020
Q1 | $5K | Sell |
28
-31
| -53% | -$6.17K | ﹤0.01% | 56 |
|
|
2019
Q4 | $12K | Hold |
59
| – | – | 0.01% | 76 |
|
|
2019
Q3 | $12K | Hold |
59
| – | – | 0.01% | 79 |
|
|
2019
Q2 | $11K | Hold |
59
| – | – | 0.01% | 83 |
|
|
2019
Q1 | $10K | Hold |
59
| – | – | 0.01% | 83 |
|
|
2018
Q4 | $11K | Hold |
59
| – | – | 0.01% | 65 |
|
|
2018
Q3 | $10K | Hold |
59
| – | – | 0.01% | 88 |
|
|
2018
Q2 | $10K | Hold |
59
| – | – | 0.01% | 92 |
|
|
2018
Q1 | $9K | Hold |
59
| – | – | 0.04% | 61 |
|
|
2017
Q4 | $9K | Hold |
59
| – | – | 0.01% | 72 |
|
|
2017
Q3 | $8K | Hold |
59
| – | – | 0.01% | 69 |
|
|
2017
Q2 | $7K | Hold |
59
| – | – | 0.01% | 69 |
|
|
2017
Q1 | $7K | Buy |
+59
| New | +$7.1K | 0.01% | 69 |
|
Other funds holding CME
Stuart Chaussee & Associates's CME Position: Q4 2025 in Review
Stuart Chaussee & Associates sold out of CME Group (CME) in Q4 2025, closing a stake of 28 shares — an estimated $7.57K sold.
Stuart Chaussee & Associates first reported a position in CME in Q1 2017 and held it in 35 quarters. The position peaked at $12K in Q4 2019. 1,736 funds tracked by Wall St. Rank hold CME as of Q4 2025.
- Stuart Chaussee & Associates reported no remaining CME Group position as of Q4 2025 after selling out during the quarter.
- Stuart Chaussee & Associates sold 28 CME Group shares in Q4 2025, an estimated $7.57K.
- Stuart Chaussee & Associates first reported a position in CME Group in Q1 2017 and held it in 35 quarters.
- Stuart Chaussee & Associates's CME Group position peaked at $12K in Q4 2019.
- 1,736 funds tracked by Wall St. Rank held CME Group as of Q4 2025.
Based on Stuart Chaussee & Associates's 13F filing for Q4 2025.